Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PULPISOLONE: Oral Prednisolone vs Partial Endodontic Treatment for Acute Irreversible Pulpitis
NCT02629042Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2017
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of prednisolone in pulpitis (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Pain intensity on a numeric scale at 24 hours. Started May 2017; status: completed.
02
Drugs
prednisolone
03
Conditions
pulpitis
Beyond the preview
Go deeper on NCT02629042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629042.